Laurion Capital Management LP Johnson & Johnson Transaction History

Laurion Capital Management LP

$7.27 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $336,405 - $367,627	2,330 New	2,330 $340,000
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $422,919 - $455,141	2,740 New	2,740 $453,000
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $22.1 Million - $24.4 Million	131,395 New	131,395 $23.3 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $1.03 Million - $1.14 Million	-6,362 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $2.51 Million - $2.7 Million	-15,760 Reduced 71.24%	6,362 $1.05 Million
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $2.11 Million - $2.35 Million	-13,802 Reduced 38.42%	22,122 $3.64 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $1.23 Million - $1.41 Million	8,958 Added 33.22%	35,924 $5.65 Million
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $9.95 Million - $10.9 Million	-70,868 Reduced 72.44%	26,966 $4.02 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $12.6 Million - $15.2 Million	97,834 New	97,834 $13.8 Million
Q4 2019 Feb 13, 2020	SELL	$127.5 - $146.44 $981,750 - $1.13 Million	-7,700 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$126.95 - $142.14 $977,515 - $1.09 Million	7,700 New	7,700 $996,000
Q2 2019 Aug 13, 2019	SELL	$131.15 - $144.24 $13,115 - $14,424	-100 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$125.72 - $139.79 $3.47 Million - $3.85 Million	-27,571 Reduced 99.64%	100 $14,000
Q2 2018 Aug 13, 2018	SELL	$119.4 - $131.76 $2.56 Million - $2.82 Million	-21,437 Reduced 43.65%	27,671 $3.36 Million
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $21.1 Million - $25 Million	-168,474 Reduced 77.43%	49,108 $6.29 Million
Q4 2017 Feb 13, 2018	BUY	$131.22 - $143.62 $28.6 Million - $31.2 Million	217,582	217,582 $30.4 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Account